Changing
Causes of Illness and Death among HIV Positive Individuals in the HAART Era By Liz Highleyman The advent of effective combination
antiretroviral therapy has dramatically reduced the frequency of AIDS-defining
opportunistic infections,
leading to a shift in the most common causes of illness and death in people with HIV.
Non-infectious chronic conditions such as liver disease (often associated with
hepatitis B or C)
and other diseases associated with aging now have more time to develop as HIV
positive people live longer. As
reported in the October 1, 2007 issue of AIDS, researchers conducted a
study to assess trends in “perimortal” conditions --
defined as pathological conditions contributing to death or present at death,
but not necessarily the reported cause of death -- during 3 periods: ·
Pre-HAART
(1992-1995); ·
Early HAART
(1996-1999); ·
Contemporary
HAART (2000-2003). They
looked at annual mortality rates and use of antiretroviral therapy among more
than 36,000 participants in the Adult/Adolescent Spectrum of HIV Disease (ASD)
cohort. Looking at patients who died between 1992 and 2003, the investigators
determined proportionate mortality for selected perimortal
conditions, annual mortality rates, and prevalence of antiretroviral therapy use,
standardized by sex, race/ethnicity, age at death, HIV transmission category,
and lowest-ever (nadir) CD4 cell count. Multivariate generalized linear regression
was used to estimate trends over time. Results ·
Of 13,895
total deaths during the study period, 9225 with recorded perimortal causes were analyzed: o
58.6% occurred
during 1992-1995; o
29.5% occurred
during 1996-1999; o
11.9% occurred
during 2000-2003. ·
Mortality
rates decreased from 487.5 to 100.6 per 1000 person-years between 1995 and 2002.
·
The rate
of decline in mortality slowed in recent years (i.e., the death rate continued
to fall, but did not fall as fast). ·
Over the
study period, individuals who died were less likely to be gay white men, more
likely to be women or black, more likely to be age 55 or older, and more often
never had a pre-treatment CD4 count below 100 cells/mm3. ·
The proportion
of deaths due to AIDS-defining infectious diseases (e.g., Pneumocystis pneumonia, non-tuberculosis mycobacterial infections, cytomegalovirus)
decreased significantly during the study period. ·
In parallel,
the proportion of deaths due to non-infectious diseases -- such as liver disease,
high blood pressure, and excessive alcohol use -- increased significantly. ·
About 75%
of cohort participants were prescribed antiretroviral therapy annually (increasing
from about 60% to about 80% between 1995 and 1997). Conclusion Based
on these findings, the authors concluded, “Among HIV-infected patients, the majority
of whom were prescribed antiretroviral therapy, the increasing trend in common
non-infectious perimortal conditions support screening and treatment for
these conditions in order to sustain the trend in declining mortality rates.” In
addition to the fact that the proportion of non-AIDS deaths by definition goes
up as percentage of mortality due to opportunistic infections goes down, the researchers
suggested that rising rates of cardiovascular disease, diabetes, and high blood
pressure may in part be attributable to HAART-related toxicities.In
a related study published in the October 2007 American Journal of Public Health,
researchers assessed differences in mortality between black and white people with
HIV/AIDS before and after the introduction of HAART. They
found that national black-white disparities in rates of death widened significantly
after the introduction of HAART, especially among women and elderly individuals.
However, neither socioeconomic status nor race/ethnicity were significant predictors after controlling for pre-HAART
mortality. Socioeconomic status, race, and pre-HAART mortality were all significant
independent predictors of mortality among black men. Based on these findings,
the researchers concluded that racial disparities “were not inevitable” and tended
to reflect pre-HAART levels. Epidemic
Intelligence Service, Office of Workforce and Career Development; Division of
HIV/AIDS Prevention; Global AIDS Program, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention,
Atlanta, GA; Public Health, Seattle and King County, Seattle, WA. Department
of Family and Community Medicine, Meharry Medical College,
Nashville, TN
10/19/07
References
D Hooshyar, DL Hanson, M Wolfe,
and others. Trends in perimortal
conditions and mortality rates among HIV-infected patients. AIDS
21(15): 2093-2100. October 1, 2007. RS Levine,
NC Briggs, BS Kilbourne.
Black-White mortality from HIV in the United States before and after introduction
of highly active antiretroviral therapy in 1996. Am J Public Health 97(10): 1884-1892. October
2007.
|